Alkermes plc - Company & Market Research Reports

Alkermes is a leader in innovative medicines that address the needs of people living with debilitating diseases. Alkermes develops products that are designed to make a meaningful difference in the way patients manage their disease. Alkermes produces innovative treatments for major clinical conditions specifically focused on central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis.


Monoclonal Antibody Based Products - Global Strategic Business Report - Product Thumbnail Image

Monoclonal Antibody Based Products - Global Strategic Business Report

  • Report
  • 527 Pages
From
Drug Delivery Systems: US Market Outlook, Advances for Pharma, Biotech & Medical Devices - Product Thumbnail Image

Drug Delivery Systems: US Market Outlook, Advances for Pharma, Biotech & Medical Devices

  • Report
  • 163 Pages
From
Generic Drug Opportunity Assessment - Asenapine (Saphris) - Product Thumbnail Image

Generic Drug Opportunity Assessment - Asenapine (Saphris)

  • Report
From
Opium (Opioid) Addiction Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Opium (Opioid) Addiction Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 340 Pages
From
Drug Addiction Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Drug Addiction Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 606 Pages
From
Alcohol Addiction Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Alcohol Addiction Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 310 Pages
From
CNS Cluster Addiction Drug Development Pipeline Review, 2017 - Product Thumbnail Image

CNS Cluster Addiction Drug Development Pipeline Review, 2017

  • Report
  • 150 Pages
From
Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, H2 2016 - Product Thumbnail Image

Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, H2 2016

  • Report
  • 64 Pages
From
Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, H1 2016 - Product Thumbnail Image

Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, H1 2016

  • Report
  • 58 Pages
From
Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies) - Product Thumbnail Image

Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)

  • Report
  • 170 Pages
From
Drug Delivery Series I-IV (Oral, Implantable/Injectable, Pulmonary and Transdermal/Transmucosal Systems) - Product Thumbnail Image

Drug Delivery Series I-IV (Oral, Implantable/Injectable, Pulmonary and Transdermal/Transmucosal Systems)

  • Report
  • 475 Pages
From
Peptide Therapeutics in Metabolic Disorders, 2016 - 2025 - Product Thumbnail Image

Peptide Therapeutics in Metabolic Disorders, 2016 - 2025

  • Report
  • 436 Pages
From
Infusion Therapy Devices Market: By Infusion Pumps; By End Use; By Accessories & Consumables; By Geography - Forecast 2015-2021 - Product Thumbnail Image

Infusion Therapy Devices Market: By Infusion Pumps; By End Use; By Accessories & Consumables; By Geography - Forecast 2015-2021

  • Report
  • 98 Pages
From
Global Substance Abuse Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2015 to 2025 - Product Thumbnail Image

Global Substance Abuse Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2015 to 2025

  • Report
From
Substance Abuse, Addiction, and Treatment: Global Markets - Product Thumbnail Image

Substance Abuse, Addiction, and Treatment: Global Markets

  • Report
  • 150 Pages
From
Vivitrol 2016 U.S Promotional Report - Product Thumbnail Image

Vivitrol 2016 U.S Promotional Report

  • Report
  • 24 Pages
From
Substance Abuse Treatment Market: By Addiction Substances; By Category & By Region - Forecast 2016-2021 - Product Thumbnail Image

Substance Abuse Treatment Market: By Addiction Substances; By Category & By Region - Forecast 2016-2021

  • Report
  • 138 Pages
From
Global Substance Abuse Treatment Market 2017-2021 - Product Thumbnail Image

Global Substance Abuse Treatment Market 2017-2021

  • Report
  • 73 Pages
From
EMEA (Europe, Middle East and Africa) Substance Abuse Treatment Market - Segmented by Abuse type, Treatment, End-User and Geography - Growth, Trend and Geography (2018 - 2023) - Product Thumbnail Image

EMEA (Europe, Middle East and Africa) Substance Abuse Treatment Market - Segmented by Abuse type, Treatment, End-User and Geography - Growth, Trend and Geography (2018 - 2023)

  • Report
  • 99 Pages
From
Opioid Receptor Antagonists- Pipeline Insight, 2018 - Product Thumbnail Image

Opioid Receptor Antagonists- Pipeline Insight, 2018

  • Drug Pipelines
  • 99 Pages
From
Loading Indicator
adroll